Greater Hemoglobin Variability on ESAs Ups Infection Risk
Whether reducing hemoglobin variability will improve patient outcomes remains unclear.
Whether reducing hemoglobin variability will improve patient outcomes remains unclear.
Study did not meet primary endpoint for composite of death, heart failure hospitalization, and exercise function
Large variation in anemia burden by age, sex, geography; burden increased for children younger than 5 years, women, those residing in sub-Saharan Africa and south Asia regions
The FDA approval of daprodustat is based on results from the ASCEND-D trial comparing daprodustat with ESAs.
In both men and women, the prevalence of severe anemia increased as kidney function decreased.
Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?
Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.
According to investigators, it is crucial to find the underlying causes of post-transplant anemia and to treat all reversible causes.
Investigators compared the therapies in a large national cohort of patients with normal kidney function.
Recent study included 980 individuals older than 65 years who participated in the Cardiovascular Health Study.